BYHERZYN Trademark

Trademark Overview

On Thursday, June 9, 2022, a trademark application was filed for BYHERZYN with the United States Patent and Trademark Office. The USPTO has given the BYHERZYN trademark a serial number of 79344453. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by Zymeworks BC Inc.. The BYHERZYN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
byherzyn

General Information

Serial Number79344453
Word MarkBYHERZYN
Filing DateThursday, June 9, 2022
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7198177
Registration DateTuesday, October 24, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZymeworks BC Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCA
Party NameZymeworks BC Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCA
Party NameZymeworks BC Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCA

Trademark Events

Event DateEvent Description
Wednesday, February 14, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 24, 2024FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 24, 2024FINAL DISPOSITION PROCESSED
Wednesday, January 24, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Monday, August 21, 2023NOTIFICATION PROCESSED BY IB
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 2, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 6, 2023REFUSAL PROCESSED BY IB
Monday, May 15, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 15, 2023REFUSAL PROCESSED BY MPU
Saturday, April 29, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, March 28, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 27, 2023NON-FINAL ACTION WRITTEN
Friday, March 24, 2023ASSIGNED TO EXAMINER
Saturday, October 8, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 12, 2022APPLICATION FILING RECEIPT MAILED
Friday, July 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

byherzyn pharmaceutical preparations oncology treatment cancer